Toolkit/open-field locomotion

open-field locomotion

Assay Method·Research·Since 2017

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs

Usefulness & Problems

Why this is useful

Open-field locomotion is presented as a common rodent behavioral measure in this research area. The abstract links such measures to mapping hyperlocomotion and related disturbances.; rodent behavioral assessment in schizophrenia-related studies; mapping hyperlocomotion-related phenotypes

Source:

Open-field locomotion is presented as a common rodent behavioral measure in this research area. The abstract links such measures to mapping hyperlocomotion and related disturbances.

Source:

rodent behavioral assessment in schizophrenia-related studies

Source:

mapping hyperlocomotion-related phenotypes

Problem solved

It provides a simple behavioral readout for schizophrenia-relevant locomotor phenotypes in cannabinoid studies. This helps map fundamental mechanisms associated with hyperlocomotion.; provides a behavioral readout for hyperlocomotion-related disturbances

Source:

It provides a simple behavioral readout for schizophrenia-relevant locomotor phenotypes in cannabinoid studies. This helps map fundamental mechanisms associated with hyperlocomotion.

Source:

provides a behavioral readout for hyperlocomotion-related disturbances

Problem links

provides a behavioral readout for hyperlocomotion-related disturbances

Literature

It provides a simple behavioral readout for schizophrenia-relevant locomotor phenotypes in cannabinoid studies. This helps map fundamental mechanisms associated with hyperlocomotion.

Source:

It provides a simple behavioral readout for schizophrenia-relevant locomotor phenotypes in cannabinoid studies. This helps map fundamental mechanisms associated with hyperlocomotion.

Published Workflows

Objective: Improve mechanistic and translational understanding of how cannabinoids and vanilloids influence schizophrenia-relevant phenotypes by combining psychopharmacological and neurophysiological tools.

Why it works: The review argues that existing behavioral and neurochemical strategies map important mechanisms but need neurophysiological tools to better inform clinical research, implying that combining these modalities improves mechanistic interpretation and translational value.

sensorimotor gatinghyperlocomotionsocial interactionmonoaminergic disturbancesglutamatergic disturbancesGABAergic disturbancesendocannabinoid-endovanilloid interplaybehavioral assaysneurochemical approachesdrug challenge designselectrophysiologyviral vector-based circuit dissectionoptogenetics

Stages

  1. 1.
    Rodent behavioral and neurochemical mapping(broad_screen)

    This stage represents the established knowledge-generating base from which much of the field's understanding has been derived.

    Selection: Use common rodent behavioral measures and associated neurochemical or drug challenge approaches to map schizophrenia-relevant mechanisms.

  2. 2.
    Human imaging and electrographic contextualization(functional_characterization)

    The review explicitly begins by contextualizing human imaging and electrographic findings before discussing rodent electrophysiology.

  3. 3.
    Rodent electrophysiology review and mechanistic interpretation(secondary_characterization)

    The review next presents rodent electrophysiology to deepen mechanistic understanding beyond behavioral readouts.

  4. 4.
    Combined psychopharmacological and neurophysiological future-direction integration(decision_gate)

    This final stage captures the review's explicit recommendation for how the field should proceed.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Input: Chemical

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenoperating role: sensor

The abstract supports use in rodents and notes that these behavioral measures are commonly used with neurochemical approaches or drug challenge designs. No protocol details are given.; used in rodent behavioral studies; commonly paired with neurochemical approaches or drug challenge designs

The review states that behavioral strategies need stronger neurophysiological support to better inform clinical research. The abstract does not claim that open-field assays resolve circuit or synaptic mechanisms.; review states that these strategies require greater use of neurophysiological tools to better inform clinical research

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1review summarysupports2017Source 1needs review

Behavioral and neurochemical strategies in this area require greater use of neurophysiological tools to better inform clinical research.

These strategies will require, however, a greater use of neurophysiological tools to better inform clinical research.
Claim 2review summarysupports2017Source 1needs review

Electrophysiology and viral vector-based circuit dissection such as optogenetics can further elucidate how exogenous cannabinoids worsen or ameliorate schizophrenia symptoms.

electrophysiology and viral vector-based circuit dissection, like optogenetics, can further elucidate how exogenous cannabinoids worsen (e.g., tetrahydrocannabinol, THC) or ameliorate (e.g., cannabidiol, CBD) schizophrenia symptoms
Claim 3review summarysupports2017Source 1needs review

Rodent behavioral measures such as prepulse inhibition and open-field locomotion, often combined with neurochemical approaches or drug challenge designs, have provided much of the field's knowledge about the endocannabinoid system in schizophrenia.

Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs.

Approval Evidence

1 source1 linked approval claimfirst-pass slug open-field-locomotion
behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs

Source:

review summarysupports

Rodent behavioral measures such as prepulse inhibition and open-field locomotion, often combined with neurochemical approaches or drug challenge designs, have provided much of the field's knowledge about the endocannabinoid system in schizophrenia.

Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs.

Source:

Comparisons

Source-stated alternatives

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Source:

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Source-backed strengths

described as commonly used in the field

Source:

described as commonly used in the field

Compared with electrophysiology

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as commonly used in the field.

Relative tradeoffs: review states that these strategies require greater use of neurophysiological tools to better inform clinical research.

Source:

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as commonly used in the field.

Relative tradeoffs: review states that these strategies require greater use of neurophysiological tools to better inform clinical research.

Source:

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as commonly used in the field.

Relative tradeoffs: review states that these strategies require greater use of neurophysiological tools to better inform clinical research.

Source:

Prepulse inhibition, neurochemical approaches, and drug challenge designs are named as related strategies. Electrophysiology and optogenetics are presented as complementary tools.

Ranked Citations

  1. 1.
    StructuralSource 1Frontiers in Pharmacology2017Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl1. Extracted from this source document.